These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18534960)

  • 1. Response of malignant thymoma to erlotinib.
    Christodoulou C; Murray S; Dahabreh J; Petraki K; Nikolakopoulou A; Mavri A; Skarlos D
    Ann Oncol; 2008 Jul; 19(7):1361-1362. PubMed ID: 18534960
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-EGFR therapy: towards a "à la carte" targeting of hepatocellular carcinoma].
    Fartoux L; Desbois-Mouthon C; Poupon R; Rosmorduc O
    Gastroenterol Clin Biol; 2006 Oct; 30(10):1133-5. PubMed ID: 17075466
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the epidermal growth factor receptor in combined modality treatment for locally advanced non-small cell lung cancer.
    Ready N
    Semin Oncol; 2005 Apr; 32(2 Suppl 3):S35-41. PubMed ID: 16015534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy.
    Ciardiello F; De Vita F
    Prog Drug Res; 2005; 63():93-114. PubMed ID: 16265878
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical treatment of non-small-cell lung cancer.
    Buter J; Giaccone G
    Ann Oncol; 2005; 16 Suppl 2():ii229-32. PubMed ID: 15958463
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of inhibitors of the epidermal growth factor in management of head and neck cancer.
    Brockstein B; Lacouture M; Agulnik M
    J Natl Compr Canc Netw; 2008 Aug; 6(7):696-706. PubMed ID: 18691458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the epidermal growth factor receptor in non-small-cell lung cancer: who, which, when, and how?
    Juergens R; Brahmer J
    Curr Oncol Rep; 2007 Jul; 9(4):255-64. PubMed ID: 17588349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor inhibition strategies in oncology.
    Harari PM
    Endocr Relat Cancer; 2004 Dec; 11(4):689-708. PubMed ID: 15613446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous side effects of EGF-receptor inhibition and their management].
    Gutzmer R; Werfel T; Kapp A; Elsner J
    Hautarzt; 2006 Jun; 57(6):509-13. PubMed ID: 16205868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitors of the EGFR pathway in non small cell lung cancer: what's new in 2007?].
    Grenier J; Soria JC
    Bull Cancer; 2007 Jan; 94(1):53-61. PubMed ID: 17237005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor inhibition in solid tumours.
    Ganti AK; Potti A
    Expert Opin Biol Ther; 2005 Sep; 5(9):1165-74. PubMed ID: 16120047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical breakthroughs in EGFR inhibition: applying the science to your clinical practice.
    Morse L
    ONS News; 2006; 21(8 Suppl):59-60. PubMed ID: 16925155
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor.
    Harichand-Herdt S; Ramalingam SS
    Semin Thorac Cardiovasc Surg; 2008; 20(3):217-23. PubMed ID: 19038731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer.
    Caponigro F
    Anticancer Drugs; 2004 Apr; 15(4):311-20. PubMed ID: 15057134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor as a therapeutic target in colorectal cancer.
    Cohen RB
    Clin Colorectal Cancer; 2003 Feb; 2(4):246-51. PubMed ID: 12620146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab and erlotinib show promise for kidney cancer.
    Lindsey H
    Lancet Oncol; 2006 Jan; 7(1):15. PubMed ID: 16408368
    [No Abstract]   [Full Text] [Related]  

  • 17. Gefitinib versus cetuximab in lung cancer: round one.
    Minna JD; Peyton MJ; Gazdar AF
    J Natl Cancer Inst; 2005 Aug; 97(16):1168-9. PubMed ID: 16106015
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidermal growth factor receptor as a target for chemotherapy.
    Vallbohmer D; Lenz HJ
    Clin Colorectal Cancer; 2005 Apr; 5 Suppl 1():S19-27. PubMed ID: 15871762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR inhibitors square off at ASCO.
    Baker M
    Nat Biotechnol; 2004 Jun; 22(6):641. PubMed ID: 15175668
    [No Abstract]   [Full Text] [Related]  

  • 20. [New biological treatments for lung cancer].
    Zalcman G; Richard N; Bergot E
    Rev Pneumol Clin; 2007 Feb; 63(1):20-8. PubMed ID: 17457280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.